LiveDrop has launched the commercialisation of the new ModaFlow 4L5C, Revolutionising biotherapeutic discovery with picoscale droplet technology. tinyurl.com/45ypnuuu

🇧🇪 UCB has started construction on its new R&D centre in Braine-l'Alleud, named Arkelia. This new facility represents an investment of over 100 million euros and is expected to be fully operational by mid-2028. UCB News tinyurl.com/5cm4pw32

Andaman7 joins the BioWin community! 🎉 We’re happy to be part of BioWin, the leading health cluster in Wallonia, Belgium! 🚀

InnoSer International announces leadership transition: Kris Motmans appointed as new CEO. InnoSer tinyurl.com/4pad3btt

Save the Date! We look forward to seeing you at the 9th edition of BioWin Day this September. This year, experience not just one but two BioWin Days and be in the front row of Belgium's health innovation. 👉 Stay updated: tinyurl.com/mv4hm3ce

4Tissue secures an additional €1.5M in funding and appoints Dr. Katleen Verleysen as independent chair of the board. tinyurl.com/3dbkw5vt

Synergia Medical announces strong results for NAO.VNS™ first-in-human study. tinyurl.com/2xfd69na

White Raven, a newly established CDMO, obtains GMP certification for its aseptic fill & finish facility with a robotic gloveless workcell for small-batch manufacturing. tinyurl.com/vyvnw4yk

KiOmed Pharma is continuing to grow, having raised €18 million to support the commercial expansion of its osteoarthritis gel and to move forward with new developments in dermatology and ophthalmology. tinyurl.com/2cmvkphc

Aptissen and kiOmed Pharma forge a strategic alliance bringing breakthrough in Osteoarthritis Treatment. tinyurl.com/tz5v4p27

One more step for AbolerIS Pharma! The biotech has just dosed the first participants in a Phase 1 trial for ABO21009, a first-in-class anti-CD45RC monoclonal antibody for rheumatoid arthritis. tinyurl.com/bddbser3

Do you have an innovative idea in health and need the right partners to bring it to life? If your project fits within one of BioWin’s strategic themes - #biopharma or #healthtech - then you may be eligible for funding. tinyurl.com/89zcx3n5

Rystiggo (rozanolixizumab) receives approval in Japan for two new administration methods as UCB begins ONWARD program for patient support. tinyurl.com/2nxv3a9w

For the first time in Belgium, two patients suffering from sarcomas, rare cancers that affect bone or soft tissue, have undergone surgery using augmented reality. tinyurl.com/ywb2macs

ATB Therapeutics Announces Appointment of Dr. Torsten Dreier as Chief Development Officer and Opening of New R&D Hub in Gent. tinyurl.com/4h4zfap2

UCB announces major U.S. investment to expand biologics manufacturing capacity. UCB News tinyurl.com/u3ckm5fe

Novadip Biosciences received RMAT designation for NVD003, its regenerative treatment for congenital pseudarthosis of the tibia. tinyurl.com/ppyd94ha

Hyloris Partners with Kuvatris Therapeutics to Advance Suramin IV Development for Sleeping Sickness, Targeting a Priority Review Voucher. tinyurl.com/52pe2fkt

Kaneka Eurogentec completes commercial mRNA GMP facility expansion. tinyurl.com/v9e7usb5

Hyloris Pharmaceuticals announces positive clinical study results for atomoxetine oral solution. tinyurl.com/2whappny